Business journalist Gary Weiss, writing for Portfolio.com, notes that the litigation by a small biotech company against a hedge fund and a research firm has ended with an apology from the company and money being paid, but the media that ran stories sympathetic to the cause of small companies being shorted by investors have yet to apologize or update their viewers.
“NBC has never revisited its Eagletech story, and neither has CBS clued in its viewers on the denouement of its Biovail story, either on the air or in the long article that CBS published on its website at the time of the broadcast. Not one word about the guilty plea, the SEC woes, or last week’s apologies.
“It seems to me that another apology is needed: an apology from CBS, not to Gradient or SAC, but to its viewers.”
Read more here.
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…
Members of the CoinDesk editorial team have sent a letter to the CEO of its…